Genitourinary Pathology

Genitourinary pathology includes diseases of the prostate, bladder, ureters, urethra, and testis. Our pathologists provide a full-range of diagnostic services including interpretation of biopsies and comprehensive evaluation of surgical resections. Immunohistochemistry and molecular diagnostic tests are used in conjunction with routine histopathology.

Experience & Expertise
The HNL Genitourinary Pathology Division encompasses the full breadth of sub-specialty diagnostic services encountered in both office and tertiary care urology practices. Our board certified pathologists review biopsy and resection specimens from all areas of the genitourinary tract. Testing as indicated includes analysis of immunohistochemistry markers to assist in the typing of kidney tumors, diagnosis of malignancy in prostate specimens and markers to fully evaluate the spectrum of differentiation in testicular germ cell tumors. Other tests are performed as needed or requested, and new markers continue to be added as they become available.

 

Pathologists & Staff 

 

Peter Fisher, M.D., MBA — President and CEO of Health Network Laboratories, Clinical Laboratory Director.

Daniel F. Brown, M.D., MBA, — Chair of the Department of Pathology and Laboratory Medicine, Medical Director, Neuropathology.

Eugene Alexandrin, M.D. — Medical Director, Genitourinary Pathology

Elizabeth A. Dellers, M.D.

Victoria Loven, MD, FCAP

Gary A. Stopyra, MD, FCAP, FASCP

Michael Scarlato, M.D. — Director, Gastrointestinal Pathology